CHRS NASDAQ · Healthcare · FY 2025-12-31

Coherus Oncology, Inc.

0.00.40.81.11.5ABVfair 0.12buy —EPVnot valid for this companyEBVnot valid for this companyDBVnot valid for this companyprice 1.41 USD
ABV EPV EBV DBV fair value / share buy at or below (margin of safety applied) margin-of-safety band current price values in USD
Verdict
Avoid
Buy zone
Overvalued
Archetype
Distressed/Deficit
Confidence
●○○ Low · 1/4

Price
1.410 USD
Market cap
170.8M USD
P / B
2.80
P / E
0.99
EPS
1.430
DPS / yield
(0.0%)
NAV / share
0.122
Graham number
4.025
Z'' score
-20.01
Piotroski F
6 / 9
Beneish M
2.92
ROIC vs WACC
-1270.6% vs 12.7%

See the full orchestrator pipeline — solvency gate, lens cascade, reconciliation, archetype, decision, and confidence.

Subscribe to unlock this and every other tab for every company.

See the full ABV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full EPV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full EBV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full DBV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.